Previous Experience

I have held a succession of senior executive positions in biotechnology, pharmaceutical, medical device companies, and diagnostic companies in the USA, Europe and Asia.

Current Positions:

  • Mark Philip Consulting LLC. President, Owner and Founder. Providing consulting service in the areas of strategy development, product development, business development, fund raising, commercial planning to a range of small and large pharmaceutical, biotechnology, medical device and diagnostic companies
  • Boston University School of Management, Questrom School of Business, Lecturer, Health Management MBA Program, Operations and Technology Department.

Past Positions:

  • Znomics, Inc., (OTCBB: ZNOM), President, CEO and Board Member of a biotech company discovering novel small molecules: sold to Cherry Tree.
  • Stryker Biotech, President, reinvigorated the strategy, turned around manufacturing, created an R&D plan, hired a top rate team, and grew sales 500%.
  • Zycos, Inc., President, CEO and Board Member, A biotechnology company: raised over $55 million in venture finance, successfully negotiated multi-million dollar partnership deals, developed a panel of drugs from inception to phase 2 clinical data culminating in a sale of the company to MGI Pharma.
  • Immuno-U.S., President, CEO and Board Member of a mid-size pharma company listed on the Swiss Stock Exchange. Grew sales growth of 100%, turned around operations, grew profits 11 fold, sold to Baxter International.
  • Cohesion Technologies Inc (NASDAQ: CSON), Board Member. A mid-size medical device company: launched two new products; sold to Angiotech.
  • Baxter International, General Manager (Renal Business, Japan) Senior management positions in Europe, USA and Japan focused on the development and commercialization of a wide range of drugs, devices and services in renal medicine.
  • Schering Plough Senior management position in product development and regulatory affairs (Kirby Warrick Pharmaceuticals)
  • Boots Pharmaceuticals Senior R&D management for anti-inflammatory program in the UK.

Mark Philip Qualifications

Industry Experience